Marsha A. Raebel, PharmD

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

This article summarizes the outcomes from a pilot online curriculum on off-label prescribing, appraising pharmaceutical information, and talking with patients about advertised medications.

Although some interventions may enhance medication safety, an electronic medical record reminder to providers may not be an efficient use of resources.